PURILAX product image

PURILAXFine

Monophasic Hyaluronic Acid Filler with Lidocaine
Main Composition
Cross-Linked Hyaluronic Acid, Lidocaine
Quantity
1.1 mL
Packing
1 Syringe / 1 Box
Country of Origin
REPUBLIC OF KOREA
BROCHURE

Product Range


PURILAX
PURILAX Fine
Small molecular HA with Lidocaine
PURILAX
PURILAX Deep
Medium molecular HA with Lidocaine
PURILAX
PURILAX Sub-Q
Large molecular HA with Lidocaine

Details about PURILAXFine


AETERDERM®
PURILAX with Lidocaine
Cross-Linked Hyaluronic Acid
Soft Uniform gel type, Easier to mold achieve Natural results
Discover PURILAX: Precision, Safety, and Stability in Every Application
The key to ensuring the safety and reliability of dermal fillers lies in mastering the art of fine-tuning their physical properties. When fillers lack precise control over their rheological properties, the risk of complications increases significantly, often leading to unsatisfactory outcomes. This challenge cannot simply be resolved with advanced manufacturing facilities alone. Instead, it requires the expertise and meticulous craftsmanship of seasoned engineers and researchers—a process that typically takes 5 to 10 years to perfect.
PURILAX stands out as a premium HA filler, crafted in state-of-the-art facilities by a team with over a decade of experience. Our experts have dedicated years to refining the delicate balance of physical properties, ensuring uniformity, stability, and an impressively low rate of complications.
With PURILAX, you're choosing a dermal filler that prioritizes precision and quality, offering consistently reliable results that professionals and patients can trust. Experience the difference of a truly complete filler.

● 24mg of highest purified HA content

● Optimized viscoelasticity for stylish molding

● Unified particle implementation technology

● Less than 0.025EU Endotoxin unit level

● User-friendly injection pressure

The Ultimate Soft & Durable
AETERDERM PURILAX with Lidocaine Cross-linked Hyaluronic Acid Filler
Monophasic Hyaluronic Gel
PURILAX Hyaluronic gel clinical study image

Stable and uniform Cross-linking

Optimized Viscoelasticity

High Cohesivity

Flexible Plasticity

- pH : 6.83
- BDDE Residue : 0 ppm
- Osmotic Pressure : 318 mmol/kg
- Endotoxin : Below 0.02 EU/mL
⦿ PURILAX Hyaluronic acid gel is manufactured by using a special grinding machine for consistent injection.
PURILAX Shape Maintenance Test

PURILAX

A Product

B Product

Before
12 hours after
48 hours after
Before
12 hours after
48 hours after
Before
12 hours after
48 hours after
Product Range
symbol_PURILAX_volume PURILAX Sub-Q
1.1 mL x 1 Syringe / Box
PURILAX sub-Q Product

Hyaluronic Acid Concentration (mg/mL)

- 24mg

Lidocaine Content (mg/mL)

- 3mg (0.3%)

MOD (Degree of Modification, mol %)

- 4.35%

Gel Type

- Monophasic

Storage Modulus(G')

- 250 ~ 350 G'

Complex Viscosity

- 300 ~ 500 pa

Injection Force (N) (30G UTW)

- 35.3 N

Injection Depth

- Subcutaneous

Duration

- 18 months

Enclosed Needle Gauge

- Needle 2 X 25G * 1/2"

symbol_PURILAX_deep PURILAX Deep
1.1 mL x 1 Syringe / Box
PURILAX deep Product

Hyaluronic Acid Concentration (mg/mL)

- 24mg

Lidocaine Content (mg/mL)

- 3mg (0.3%)

MOD (Degree of Modification, mol %)

- 2.85%

Gel Type

- Monophasic

Storage Modulus(G')

- 150 ~ 200 G'

Complex Viscosity

- 200 ~ 300 pa

Injection Force (N) (30G UTW)

- 27.2 N

Injection Depth

- Mid dermis

Duration

- 12 months

Enclosed Needle Gauge

- Needle 2 X 25G * 1/2"

symbol_PURILAX_fine PURILAX Fine
1.1 mL x 1 Syringe / Box
PURILAX fine Product

Hyaluronic Acid Concentration (mg/mL)

- 24mg

Lidocaine Content (mg/mL)

- 3mg (0.3%)

MOD (Degree of Modification, mol %)

- 1.75%

Gel Type

- Monophasic

Storage Modulus(G')

- 30 ~ 100 G'

Complex Viscosity

- 100 ~ 200 pa

Injection Force (N) (30G UTW)

- 14.9 N

Injection Depth

- Superficial ~ Mid dermis

Duration

- 12 months

Enclosed Needle Gauge

- Needle 2 X 25G * 1/2"

Effectiveness
Viscoelasticity
PURILAX HA gel image
◉ The role of hyaluronic acid is to increase moisture, retain collagen, and provide elasticity and flexibility.
◉ High viscoelasticity allows to maintain good volume for long duration.
Exceptional Volumizing Capacity
PURILAX lifting in volumizing test sheet, PURILAX shows the highest results compared to other fillers
Proven Biocompatibility
◉ PURILAX uses only the highest-grade raw materials to preserve natural skin integrity and allow products to distribute evenly in connective tissue with the minimum probability of causing inflammatory cells.
◉ PURILAX has a great biointegration and high tolerability profile and has been verified to be endotoxin-free and BDDE-free.
◉ Their safety has also been confirmed by the biocompatibility tests conducted according to the ISO classification.
Analysis Condition
Equipment
Model : MCR 302e
temperature
25℃
frequency
0.01 Hz to 10 Hz
Shear strain
1.0 %
Samples
11
Comparison
hyaluronic acid gels are commonly injected into the skin to improve facial appearance. The different processes used in their manufacture and formulation generate products with unique rheological properties that play an important role in their clinical performance.
These three rheological properties are the most important in determining the performance of hyaluronic aicd :
PURILAX cross-llinked HA molecules
Cohesivity
For excellent tissue integration
Viscoelasticity
For optimal tissue support
Plasticity
For excellent cohesivity
Cohesivity
◉ PURILAX's unique viscoelastic properties and variable density allow for homogeneous soft tissue augmentation and rejuvenation.
◉ The PURILAX range integrates naturally into the skin to produce predictable and natural results.
◉ These optimized rheological properties result in seamless dermal integration.
Convenience Extrusion Force
A consistent extrusion force allows for a smooth and voncenient injection.
PURILAX clinical test sheet : Extrusion force test
AETERDERM PURILAX with Lidocaine Cross-linked Hyaluronic Acid Filler
Before & After
Crow's feet & Eye area
PURILAX eye area treatment before photo
PURILAX eye area treatment after photo
Used Product

- PURILAX Fine

Used Needle Gauge

- 30G

Injection Amount

- 2.2 cc

References ) Clinical trials by Dermatol Ther 2022:19:28-29
NOTE ) After the procedure, the shallow and long wrinkles under the eyes were noticeably improved, and the deep crow's feet wrinkles had the greatest improvement. By injecting small-molecule HA(PURILAX Fine filler), it was confirmed that hydration also improved overall skin radiance and blotchy redness.
Fullness of lips
PURILAX lips treatment before photo
PURILAX lips treatment after photo
Used Product

- PURILAX Deep

Used Needle Gauge

- 27G

Injection Amount

- 1.1 cc

References ) Clinical trials by Dermatol Ther 2022:27:37-38
NOTE ) After one week of injection of medium-sized molecule HA (PURILAX Deep filler) into the lip area, the filler molecules were stably and naturally positioned in the lip dermis tissue, and no significant toxic reactions were observed.
Forehead wrinkles & Volumizing
PURILAX forehead treatment before photo
PURILAX forehead treatment after photo
Used Product

- PURILAX Sub_Q

Used Needle Gauge

- 25G

Injection Amount

- 4.4 cc

References ) Clinical trials by Dermatol Ther 2022:31:43-48
NOTE ) Large-molecule HA (PURILAX Sub_Q filler) was injected into a 32-years-old female patient to improve severe to moderate forehead wrinkles. After ten days, the HA gel that had settled subcutaneously was stable and natural, and no noticeable deformation was observed after the procedure.
Indication
symbol_PURILAX_volume PURILAX Sub-Q
PURILAX forehead treatment before photo
symbol_PURILAX_volume PURILAX Deep
PURILAX forehead treatment before photo
symbol_PURILAX_volume PURILAX Fine
PURILAX forehead treatment before photo